Clinical Trials Browser

Phase 3 × Dexamethasone × Genitourinary × Clear all

NCT06136624 2026-03-11

OMAHA-003

Phase 3 Recruiting

Prostate Cancer Metastatic

NCT06136650 2026-03-09

MK-5684-004

Phase 3 Recruiting

Prostatic Neoplasms

NCT03834506 2025-07-18

KEYNOTE-921

Phase 3 Completed

1,030 enrolled 24 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT04907227 2024-07-12

KEYNOTE-921

Phase 3 Terminated

81 enrolled 19 charts

Parkinson Disease 4, Autosomal Dominant Lewy Body, Prostatic Neoplasms

NCT00060398 2023-06-15

Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer

Phase 3 Completed

Classical hematologyGenitourinary

Anemia, Fatigue, Prostatic Neoplasms

NCT00288080 2022-06-21

Hormone Therapy and Radiation Therapy or Hormone Therapy and Radiation Therapy Followed by Docetaxel and Prednisone in Treating Patients With Localized Prostate Cancer

Phase 3 Completed

612 enrolled 11 charts

Prostatic Neoplasms

NCT03193788 2017-06-21

PREMIER

Phase 3 Unknown

Urinary Bladder Neoplasms, Carcinoma, Transitional Cell, Ureteral Neoplasms

NCT01188187 2016-10-14

SYNERGY

Phase 3 Completed

Prostatic Neoplasms

NCT00024167 2016-03-22

Chemotherapy With or Without Strontium-89 in Treating Patients With Prostate Cancer

Phase 3 Terminated

265 enrolled 9 charts

Prostatic Neoplasms

NCT00316927 2013-06-26

Dexamethasone, Aspirin, and Diethylstilbestrol in Treating Patients With Locally Advanced or Metastatic Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms